2008 FastTrac® TechVenture™ Company of the Year

2008 FastTrac Tech Company of the Year

Oncoscope, Inc.

Oncoscope develops proprietary optical systems that accurately locate pre-cancerous cells in epithelial tissues including the esophagus, colon, lung, bladder and cervix. This breakthrough technology provides non-invasive, high-coverage detection of cancer not possible with existing methods. Total market opportunity is more than $1B with the first product for guided biopsy of the esophagus having a US market opportunity of $225M. Commercial product development is underway with a 510(k) path to FDA clearance expected.

What Members are Saying

"CED is very useful in helping network and gather people. For early entrepreneurs, CED is one of the best resources for getting things done." -Dr. John Ryals, CEO, Metabolon (also founder and former CEO of Paradigm Genetics)